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ABSTRACT
Objective: The purpose of this study was to estimate the association
between obesity and diabetes among inpatients in the United States as well
as to investigate the incremental hospital charges attributable to obesity or
morbid obesity.
Methods: We analyzed the Nationwide Inpatient Sample 2005, a nation-
ally representative probability sample that includes nearly 8 million in-
patient records from US community hospitals.
Results: During the past decade, the obesity among inpatients has steeply
increased. In 2005, nearly 1.87 million hospitalizations were made by
obese or morbidly obese patients. Both patients with type 1 and type 2
diabetes were considerably more likely to be obese or morbidly obese
compared with inpatients without diabetes (P < 0.01). The proportions of
hospitalizations with obese or morbidly obese conditions were 4.5%
among patients without diabetes, 6.5% among patients with type 1, and
12.2% among patients with type 2 diabetes. The hospital charges for
obese and morbidly obese patients were 6.1% (P < 0.01) and 18.7%
(P < 0.01) higher than that of the nonobese patients when diabetes status,
sex, age, race, hospital admission type, and length of hospital stays were
the same.
Conclusions: Following a parallel rise in obesity among the general popu-
lation, hospital admissions of obese and morbidly obese inpatients are
continuously increasing. Morbidly obese patients consumed substantially
more hospital resources regardless of the presence or type of diabetes.
Under the current price-per-case reimbursement system, additional hospi-
tal resource use by this growing number of morbidly obese inpatients
could be a burden to hospital ﬁnancial systems.
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Introduction
The prevalence of obesity, which is deﬁned as having a body mass
index (BMI) greater than 30 kg/m2, has substantially increased
over the past couple of decades within the United States [1,2].
Extreme obesity, which is deﬁned as having a BMI greater than
40 kg/m2 [3], is also known as “morbid” obesity because it is
associated with various life-threatening diseases. The prevalence
of morbid obesity has been increasing at a faster rate than that of
obesity over the past 20 years [4]. A study based on the Behav-
ioral Risk Factor Surveillance Survey has reported that, from
2000 to 2005, the prevalence of obesity among adults in the
United States increased by 24%. However, the prevalence of
morbid obesity increased by 50% [4]. This continually increasing
prevalence of obesity and morbid obesity in the US population
remain a signiﬁcant public health concern because of its various
negative impacts on health.
It is well documented that obesity is positively associated
with type 2 diabetes in the general population [2,5–9]. Type 1
diabetes, known as an autoimmune disease, was also reported
to be linked to obesity among children [10–12]. A more recent
study suggested that obesity is a risk factor for the early onset
of type 1 diabetes among US youths with reduced b-cell func-
tions [13]. The number of young adults hospitalized with
diabetes has increased signiﬁcantly over the last decade
[14], following a parallel rise in obesity among the general
population. Although the link between obesity and diabetes is
found in the general population, there is little information
about the association between obesity and diabetes among
inpatients. The aim of our study was to estimate the level of
obesity and morbid obesity among hospitalized patients with
type 1 or type 2 diabetes.
Moreover, the purpose of this study was to describe the
incremental hospital charges attributable to obesity or morbid
obesity among inpatients with and without diabetes. Obese
patients had a signiﬁcantly higher number of visits to both
primary care and specialty care clinics [15]. The costs of the
health services rendered to obese persons also tended to be higher
[16]. According to a review study [17], the excess use and cost of
medical services are because of obesity-related comorbidity. The
above referenced study concluded that the increased health-care
expenditure was linked with obesity, largely because the obese
patients were more likely to have diseases such as diabetes or
hypertension. To our knowledge, however, no study has further
reported the hospital resource use by obesity level after control-
ling for diabetes. A study on pediatric patients reported that
obesity is associated with signiﬁcantly higher charges for the
most common reasons for pediatric hospitalizations such as
appendicitis, asthma, pneumonia, and affective disorders [18].
Because these pediatric conditions were not necessarily obesity-
related diseases, we hypothesized that obesity or morbid obesity
also plays a signiﬁcant role in hospital resource use, regardless of
the presence or absence of diabetes. Therefore, we proposed to
compare hospital charges by obesity level after controlling for
diabetes status. Because the prevalence of obesity and morbid
obesity is high in the US population, understanding the hospital
resources used by these patients is signiﬁcant to hospital ﬁnance
systems.
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Research Design and Methods
The Nationwide Inpatient Sample (NIS) was analyzed to study
obesity and morbid obesity among inpatients in the United
States.
NIS-2005
The NIS-2005, a part of the Healthcare Cost and Utilization
Project (HCUP), is a nationally representative database of hos-
pital inpatient stays. The NIS is the only all-payer inpatient care
database in the United States [19,20]. The NIS is the principal
source for national data concerning characteristics of patients
discharged from nonfederal, short-stay community hospitals.
This annual cross-sectional survey is conducted under the aus-
pices of the Agency of Health Research and Quality (AHRQ),
and the database is available to researchers upon completion of
the HCUP data use agreement course. The NIS is a probability
sample of 20 percent of the US community hospitals used to
produce a nationally representative sample. All inpatient records
in the sampled hospitals were then included. In 2005, the NIS
contained a probabilistic sample of ~8 million (n = 7,995,048)
records from over 1000 hospitals. Details concerning sampling
procedures are published elsewhere [21]. Admissions that
resulted from childbirth and newborn babies were excluded from
this study.
Diagnosis Codes for Obesity, Morbid Obesity,
and Diabetes
All primary and secondary diagnosis ﬁelds in the inpatient record
were evaluated to identify obesity and the type of diabetes.
Morbidly obese (or extremely obese) patients may require a
different amount of hospital resources compared with obese
patients. Therefore, obesity was differentiated into two groups:
obesity and morbid obesity. The obesity group was identiﬁed by
International Classiﬁcation of Diseases, Ninth Revision, Clinical
Modiﬁcation (ICD-9-CM) code = 278.00 which is deﬁned as “an
increase in body weight beyond the limitation of skeletal and
physical requirements as the result of excessive accumulation of
body fat.” In adults, a BMI of 30 or more is considered obese.
Morbid obesity (identiﬁed by ICD-9-CM code: 278.01) is diag-
nosed when the patient weighs two or more times the ideal body
weight, when the patient is more than 100 lbs above the ideal
body weight, or when the BMI is 40 or more. An obese but not
morbidly obese condition is referred to as “obesity” hereafter.
The type 1 diabetes condition is identiﬁed by ICD-9-CM code
250.X1 or 250.X3 and the type 2 diabetes condition is identiﬁed
by ICD-9-CM code 250.X0 or 250.X2, where X = 0 to 9. If at
least one diagnosis ﬁeld indicated one type of diabetes, then the
inpatient records were selected and named with “hospitalizations
with type 1” or “hospitalizations with type 2.” Further, to iden-
tify the most common reason of hospitalizations for each type of
diabetes group, the primary ICD-9-CM code was studied. The
primary diagnosis in the patient record is the condition chieﬂy
responsible for the patient’s admission to the hospital.
Estimation of Hospital Charges and Costs
By the type of obesity, the ﬁnancial burden of hospitalizations
was estimated using hospital charges and hospital costs. Hospital
charges refer to the amount the hospital billed alone, and do not
include professional (physician) fees. The hospital costs were
then estimated by multiplying the average cost-to-charge ratios
found from the cost-to-charge ratio ﬁle provided by the AHRQ
[22]. The AHRQ’s cost-to-charge ratio ﬁle is constructed using
all-payer, inpatient cost and charge information from the detailed
reports by hospitals to the Center for Medicare and Medicaid
Services. The term “attributable charges or costs” was used to
denote the differences in hospital resource use for obese inpa-
tients compared with that of nonobese inpatients.
Statistical Analysis
HCUPnet, a web-based interactive analytic tool, was used to
identify the trend of obesity and morbid obesity among inpa-
tients from 1996–2005 [23]. To evaluate a trend during this time
period, a scatter-plot was constructed. Different linear trends in
different time periods were modeled using piecewise linear
regression. Piecewise regression models are broken-stick models,
where two or more lines are joined at breakpoints [24].
Because the NIS is a probabilistic sample survey, the sampling
weight and sampling design were considered in calculating total
hospitalizations and their standard errors. Sampling weights
were used to account for unequal sampling probabilities and to
produce estimates for all hospital discharges in the United States.
The population estimation was weighted considering: 1) prob-
ability of selection; and 2) the nonresponse rate of the hospital.
To evaluate the association between obesity and diabetes
among inpatients, we used design-based Pearson chi-square sta-
tistics. Although this test is based on Pearson chi-square statis-
tics, it was reported as an F statistic adjusting for effects of survey
design used in the NIS. The odds of being obese (or morbidly
obese) were then calculated for each group of “with diabetes”
and “without diabetes.” For each group of with or without
diabetes, the number of admission records that had a diagnosis of
obesity (or morbid obesity) was the numerator of the odds, and
the remaining admission records that did not include a diagnosis
of obesity were classiﬁed as the denominator of odds. Finally, the
odds ratio of hospitalization was then calculated by dividing the
odds of being obese (or morbidly obese) among inpatients with
each type of diabetes by that of individuals without diabetes. The
statistical signiﬁcance of the odds ratio was calculated using
design-based logistic regression.
The hospital charges to patients were highly skewed, owing to
the extremely high charges generated by few very sick patients.
After we examined the skewness of the distribution, we used a
median test to compare hospital charges among nonobese, obese,
and morbidly obese groups. Finally, we compared hospital charges
among different obesity levels after controlling for potential
confounders (diabetes status, age, sex, race, admission type, and
length of hospital stay) using a linear model. To normalize the
distribution of hospital charges, these hospital charges were log-
transformed before being ﬁtted to the linear model. Details con-
cerning log transformation are published elsewhere [25]. Brieﬂy,
the sample arithmetic mean of the log-transformed hospital
charges is the log of the geometric mean which is denoted by lnG.
ln( ) ln( ) ln( ) ln( ) ln( )
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Note that the geometric mean, found by exponentiating the
arithmetic mean of the log-transformed charges, is lower than the
arithmetic mean of actual hospital charges and that is a symptom
of a positively skewed distribution. The bigger the difference
between arithmetic and geometric means, the more the data is
positively skewed. If the data is normally distributed, the two
values would be almost identical.
The variable of interest was the obesity group which has three
levels (not obese, obese, and morbidly obese). Two dummy vari-
ables were created using the “not-obese” as a reference group.
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The following regression model was ﬁtted to the data to evaluate
the role of obesity in hospital charges.
ln( )Hospital Charges obesity morbid obesityi
kX
= + ∗ + ∗ +
∑
β β β
β
0 1 2
k i+ ε (2)
where ln denotes the natural logarithm function and “k” is the
number of confounding variables controlled. In the log scale, b1
is the difference in the log of geometric means of the hospital
charges between the obese patients and nonobese patients,
although all other variables in the model were held constant.
β1 = − =ln ln ln ( )
( )
G G
G
G
obese not obese
obese
not obese
(3)
In the original scale of the hospital charges, the exponentiated
(or antilog) coefﬁcient for the obesity group, exp(b1) represents
the ratio of the geometric mean of obese patients compared with
nonobese patients after controlling for confounders in the model.
By subtracting 1 from both sides of the equation, we calculated
relative change in hospital charges.
exp( )
( ) ( )
( )
β1 1− = −G G
G
obese not obese
not obese
(3)
Thus, 100[exp(b1) - 1]% is the expected percent change in
hospital charges for obese patients compared with not-obese
patients, although all other variables in the model were held
constant. To calculate the 95% conﬁdence interval (CI) on the
original scale of hospital charges, the CI for the log scale was
obtained. Then, we antilog these limits to give a CI for the
hospital charges itself. Therefore, the observed hospital charge is
not in the center of the CI because of the asymmetrical nature of
the log scale. All analysis of the NIS-2005 was performed using
the statistical package, STATA version 10.0 [26].
Results
Hospitalizations made by Obese or Morbidly
Obese Patients
Over the past decade (between 1996 and 2005), the number of
hospitalizations by obese and morbidly obese patients have been
rapidly on the rise. Figure 1 shows this upward trend with a 95%
CI for the number of hospitalizations by obese and morbidly
obese patients. The increase in hospitalizations by morbidly
obese patients was steeper than that of obese patients; the
number of hospitalizations by obese and morbidly obese patients
increased by two and four times, respectively. The increase in the
number of hospital admissions by obese and morbidly obese
patients was noticeably accelerated after the year 2000. The
piecewise linear regression line in Figure 1 showed that the
number of obese patients increased by 21,000 each year before
the year 2000. However, from the year 2000, the number of
obese patients increased by 86,000 every year. These changes in
the rates (or slopes) were statistically signiﬁcant (P < 0.01). In the
year 2000, there was not only a change in the rate of increase but
there was also a discontinuous jump in the number of hospital
admissions by obese patients (P < 0.01). Likewise, the number of
hospitalizations by morbidly obese patients increased at a signiﬁ-
cantly steeper rate after the year 2000 (P < 0.01). Until the year
2000, the number of morbidly obese patients increased by
37,000 every year compared with an increase of 80,000 every
year after the year 2000. However, there was no discontinuous
jump in the number of hospitalizations by morbidly obese
patients in the year 2000 (P < 0.33).
In 2005, ~0.01% of discharge records listed both ICD-9-CM
codes of obesity and morbid obesity, and these patients were
considered morbidly obese. During 2005, among ~30.8 million
(95% CI: 29.6–31.9 million) hospitalizations in the United
States, nearly 1.87 million (~6%) hospitalizations listed obesity
or morbid obesity as their comorbidity. Among these 1.87
million hospitalizations, ~1,157,000 hospitalizations were made
by obese patients and another 708,000 hospitalizations were
made by morbidly obese patients. We examined the most
common reason for hospitalization by obesity level. The most
common reasons for hospitalization were congestive heart failure
accounting for 7% of nonobese inpatients, coronary atheroscle-
rosis and other heart disease accounting for 9.4% of obese inpa-
tients, and nutritional endocrine and metabolic disorders
accounting for 10.7% of morbidly obese inpatients.
Diabetes and Obesity among Inpatients
Among the 6.42 million hospitalizations made by people with
diabetes in 2005, ~5.99 million (95% CI: 5,840,000–6,132,000)
0
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Figure 1 Trend of the total number of hospital-
izations by obese (ICD-9-CM code 278.00 is
deﬁned as body mass index [BMI] of 30 or more,
or morbidly obese (ICD-9-CM code 278.01 is
deﬁned as BMI of 40 or more, or when the patient
is more than 100 lbs above the ideal body weight)
patients in the United States. Error bars represent
95% conﬁdence intervals for the given year. Lines
represent the ﬁtted line of a piecewise linear
regression.
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hospitalizations were made by patients with type 2 diabetes and
~435,000 (95% CI: 417,000–453,000) hospitalizations were
made by patients with type 1 diabetes. There was a signiﬁcant
positive association between obesity and diabetes among inpa-
tients (Pearson chi-square statistics, P < 0.01). Explicitly, as
shown in Figure 2 among hospitalizations without diabetes,
4.5% were obese or morbidly obese (2.94% obese + 1.59% mor-
bidly obese) compared with 6.5% (3.74% was obese people and
2.77% morbidly obese) among hospitalizations with type 1 dia-
betes. If the inpatient was obese or morbidly obese, the odds of
having type 1 diabetes increased by 1.3 and 1.8 times. Design-
based survey logistic regression revealed that these odds ratios
were signiﬁcantly larger than one (both P < 0.01). Among hos-
pitalizations with type 2 diabetes, 12.2% were obese or morbidly
obese people (7.09% obese + 5.14% was morbidly obese). If the
inpatient was obese or morbidly obese, the odds of having type 2
diabetes increased by 2.6 and 3.5 times, respectively. These odds
ratios were signiﬁcantly different than one (both P < 0.01).
Hospital Resources Use by Obesity Adjusting for
Diabetes and Age
We examined the distribution of the hospital charges. Skewness
of distribution for all three obesity categories was greater than
ﬁve. Because of the extreme skewness of the distribution of the
hospital charges, the group mean did not represent the center of
distribution. The median, typical hospital charge was compared
among three groups. The median hospital charge for morbidly
obese patients (US$19,425) was higher than that of the hospital-
izations of obese (US$16,012) or not obese (US$14,569) patients
(median tests for all three pairs, P < 0.05). During the same time
period, the average cost-to-charge ratio was calculated to be
0.523 in the nation. That is, approximately 52.3% of hospital
charges were actual hospital costs incurred [22]. Therefore, the
typical hospital cost incurred for morbidly obese patients was
US$2,525 more than nonobese patients as calculated by
0.52 ¥ (US$19,425–US$14,569).
We further compared the median hospital charges by obesity
controlling for age and diabetes condition (Table 1). We included
the mean hospital charges in Table 1 to illustrate that hospital
charges were positively skewed. Note that mean hospital charges
were almost double that of the medians. Medians were used for
comparison of hospital charges among the three levels of obesity.
As shown in Table 1, regardless of the presence or type of dia-
betes, the median hospital charges were much higher among
morbidly obese inpatients. Among hospitalizations without dia-
betes, the median hospital charges for nonobese, obese, and
morbidly obese patients were US$14,147, US$15,623, and
US$20,046, respectively. The same pattern of increase was
observed among hospitalizations with type 1 diabetes
(US$13,569 for nonobese, US$14,412 for obese, and US$17,540
for morbidly obese patients) and type 2 diabetes (US$16,112 for
nonobese, US$16,347 for obese, and US$18,360 for morbidly
obese patients). In terms of statistical signiﬁcance, all pairs of
three medians were signiﬁcantly different (median test, all
P-values <0.01) for patients without diabetes, with type 1 diabe-
tes, or with type 2 diabetes. From the perspective of practical
signiﬁcance, the median hospital charge among morbidly obese
patients was much larger than that of obese or nonobese patients.
This observation held true for all age groups.
Hospital Resources’ Use by Obesity after Controlling for
Potential Confounders
We started with a model with the obesity category alone. All
coefﬁcients were statistically signiﬁcant at an alpha level of 0.05.
The ﬁtted regression line was as follows
Ln obesityiHospital Charges( ) = + ∗ +9 630152 0 0709302
0 2276906
. .
. ∗ +morbid obesity iε
The exponentiated coefﬁcient, exp(0.0709302) = 1.074, is the
ratio of the expected geometric mean for obese patients over the
expected geometric mean for the nonobese patients. Therefore, we
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Figure 2 Differential level of obesity by presence
or type of diabetes among hospitalizations in the
United States, 2005. (1)All hospitalizations exclud-
ing normal delivery and newborns. (2) Obese:
body mass index (BMI) of 30 or more. (3) Mor-
bidly Obese: patient is more than 100 lbs above
the ideal body weight, or when the BMI is 40 or
more. (4) There was a signiﬁcant positive associa-
tion between diabetes and obesity among inpa-
tients (Design-based Pearson chi-square statistics,
P < 0.01).
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concluded that hospital charges would be 7.4% higher for the
obese patients than for the nonobese patients. Because the expo-
nentiated coefﬁcient for morbid obesity, exp(0.22769), equals
1.256, we conclude that hospital charges would be 25.6% higher
for the morbidly obese patients than for the nonobese patients.
We further compared the hospital charges among obesity
groups after controlling for the diabetes status, age (<20, 20–39,
40–59, 60+), sex, race (whites, blacks, Hispanics, others), hospi-
tal admission type (emergency, urgent, others), and length of
hospital stay in days. The linear model is presented in Table 2.
The exponentiated coefﬁcient for the obese group is now
exp(0.059087) = 1.061. Hospital charges were 6.1% higher for
obese patients compared with nonobese patients (95% CI: 5.6 to
6.5) although other variables in the model were held constant.
Likewise, the exponentiated coefﬁcient for morbid obesity is
exp(0.171552) = 1.187. The hospital charges for morbidly obese
patients were 18.7% higher (95% CI; 18.1–19.4%) than that of
the nonobese patients when other variables in the model were
controlled.
Admitted Primarily Because of Nonhypertensive
Congestive Heart Failure
The increased hospital charges for obese or morbidly obese
patients were signiﬁcant, regardless of the diabetes status, sex,
age, race, hospital admission type, or length of hospital stay.
Therefore, we further evaluated hospital charges among those
who had the same primary diagnosis. The most frequent primary
Table 1 Median and mean hospital charges in US dollars by different level of obesity among inpatients with or without diabetes
Total
Age in
years
Not obese* Obese, but not morbidly obese† Morbidly obese‡
Median charges Mean charges* Median charges Mean charges Median charges Mean charges
No diagnosed diabetes
<20 8,546 20,819 10,226 19,418 15,201 27,925
20–39 11,083 19,795 11,714 18,326 19,254 25,828
40–59 14,685 26,053 15,539 23,795 20,269 29,235
60+ 16,923 29,225 19,571 28,878 20,981 32,253
Total 14,147 25,985 15,623 24,460 20,046 29,057
Type 1 diabetes <20 7,674 12,434 9,556 16,393 10,999 24,947
20–39 11,243 20,804 12,210 17,805 14,138 23,449
40–59 15,392 29,444 14,364 23,468 17,925 29,545
60+ 18,396 33,780 16,944 28,344 19,015 32,073
Total 13,569 26,495 14,412 23,784 17,540 27,102
Type 2 diabetes <20 8,915 20,068 8,568 15,584 11,233 25,383
20–39 11,650 20,495 11,825 18,877 16,803 25,054
40–59 15,342 26,401 15,523 24,580 18,588 28,096
60+ 16,688 27,690 17,921 27,895 18,551 29,912
Total 16,112 27,105 16,347 25,863 18,360 28,503
*Deﬁned as body mass index (BMI) less than 30.
†ICD-9-CM code 278.00 is deﬁned as BMI of 30 or more.
‡ICD-9-CM code 278.01 is deﬁned as BMI is 40 or more or when patient is more than 100 lbs above the ideal body weight.
Note: Hospital charges reﬂect only the amount billed by the hospital for the hospital stay and does not include professional physician fees.
ICD-9-CM, International Classiﬁcation of Diseases, Ninth Revision, Clinical Modiﬁcation.
Table 2 Comparison of log-transformed hospital charges among three obesity categories after controlling for confounders
Variables Coefﬁcient. P-value exp(Coefﬁcient) Percent change in hospital charges*
Constant 8.842568 95% conf. interval
Obesity (ref: Not obese) % change lower upper
Obese† 0.059087 0.01 1.061 6.1 5.6 6.5
Morbidly obese‡ 0.171552 0.01 1.187 18.7 18.1 19.4
Diabetes (ref: No diabetes)
Type 1 diabetes 0.036901 0.01 1.038 3.8 3.1 4.5
Type 2 diabetes 0.005794 0.01 1.006 0.6 0.4 0.8
Sex (ref: Male)
Female -0.091256 0.01 0.913 -8.7 -8.9 -8.6
Age (ref: 20 or younger)
20–39 years old 0.193102 0.01 1.213 21.3 20.9 21.7
40–59 years old 0.438059 0.01 1.550 55.0 54.5 55.5
60 or older 0.508354 0.01 1.663 66.3 65.8 66.8
Admission type (ref: Emergency)
Urgent -0.072273 0.01 0.930 -7.0 -7.2 -6.8
Others 0.213435 0.01 1.238 23.8 23.6 24.0
Race (ref:Whites)
Blacks -0.008123 0.01 0.992 -0.8 -1.1 -0.6
Hispanics 0.172706 0.01 1.189 18.9 18.5 19.2
Others 0.046532 0.01 1.048 4.8 4.4 5.2
Length of stay
Hospital stay in days 0.070476 0.01 1.073 7.3 7.3 7.3
*Percent change in hospital charges given one unit change in covariate. For instance, we expect approximately 18.7% increase in the geometric mean of hospital charges for morbidly obese
patients compared with not-obese patients.
†ICD-9-CM code 278.00 is deﬁned as BMI of 30 or more.
‡ICD-9-CM code 278.01 is deﬁned as BMI is 40 or more or when patient is more than 100 lbs above the ideal body weight.
BMI, body mass index; ICD-9-CM, International Classiﬁcation of Diseases, Ninth Revision, Clinical Modiﬁcation.
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diagnosis among hospitalizations with type 2 diabetes was non-
hypertensive congestive heart failure. Among hospitalizations
with type 2 diabetes—primarily because of nonhypertensive con-
gestive heart failure—the median hospital charges for non-obese,
obese, and morbidly obese were US$14,775, US$14,876, and
US$15,776, respectively (not shown in the table). The difference
in median hospital charges between nonobese and obese patients
was insigniﬁcant (median test, P < 0.53). However, the median
hospital charge for morbidly obese patients was signiﬁcantly
higher than that of nonobese or obese patients (median test,
P < 0.01).
Comment
Following a parallel rise in obesity among the general population
in the United States, our study found a signiﬁcant growth of
obese inpatients during the same time period. A growing preva-
lence of obesity among Americans seems to continuously con-
tribute to the high demand in hospital care. We cautiously foresee
that obesity may become a frequent comorbidity among inpa-
tients in the United States for many decades to come. Another
noticeable trend is an accelerated increase in the rate of obese or
morbidly obese patients from the year 2000. ICD-9 code 278.0
was split into 278.00 and 278.01 in 1995, and the observed
increase in obese patients in 2000 are unlikely to be explained by
the change in ICD-9 coding. Parallel to the steep rise of morbid
obesity in the US general population [4], the growth of hospital
admissions by morbidly obese patients was signiﬁcantly steeper
than that of obese patients. A rapid increase in morbid obese
inpatients may be explained in part by an upward trend in
utilization of bariatric surgery in the United States [27]. From
1998 to 2004, the total number of bariatric surgeries increased
by ninefold from 13,386 to 121,055 [27]. Our study found that
the total 708,000 hospitalizations were made by morbidly obese
patients during 2005. Although it is rapidly growing, the pro-
portion of bariatric surgery still remains relatively small (~17%)
among morbidly obese patients. Our database does not include
variables to answer why there was acceleration in the increase in
obese patients and it is beyond the scope of this current study.
However, we reﬂect on an advancement of medicine which made
obese people live longer with chronic conditions in addition to an
increasing prevalence of obesity in the US population.
Obesity is a well-recognized risk factor for type 2 diabetes.
Our study found a dose–response association between obesity
level and type 2 diabetes among inpatients in the United States. If
the inpatient had type 2 diabetes, the odds of being obese and
morbidly obese increased by 2.6 and 3.5 times, respectively.
Although the association was not as strong, inpatients with type
1 diabetes were more likely to be obese or morbidly obese com-
pared with inpatients without diabetes. According to the accel-
erator hypothesis [11,12], excess body weight speeds the onset of
diabetes in children, and this hypothesis views type 1 and type 2
diabetes as the same disorder of insulin resistance. NIS data does
not include the age of onset of diabetes and we could not
contribute to the growing debate of accelerator hypothesis.
However, our study supported that there was a positive relation-
ship between obesity level and type 1 diabetes among inpatients.
That is, if the inpatient was obese or morbidly obese, the odds
of having type 1 diabetes increased by 1.3 and 1.8 times,
respectively.
A previously published study concluded that the higher cost
of medical services among obese people was largely because of
the high prevalence of obesity-related diseases such as diabetes
[17]. Our study supported that high obesity level is also indepen-
dently associated with higher levels of hospital resource use apart
from the patients’ diabetes status. We found that morbidly obese
patients consumed more hospital resources regardless of the pres-
ence or type of diabetes. Even if patients were admitted with the
same primary diagnosis of nonhypertensive congestive heart
failure, morbidly obese patients used more resources than not
morbidly obese patients. NIS data collected for administrative
purposes do not include the breakdowns of hospital charges.
Further study is needed to investigate the reasons that contribute
to the increased use of hospital charges among morbidly obese
patients. Regardless, the incremental use of hospital resources by
morbidly obese patients provides signiﬁcant information in the
current reimbursement system. The Diagnosis Related Group
(DRG) is a prospective, patient-classiﬁcation scheme used for the
price-per-case reimbursement. Medicare provides payments to
hospitals for inpatient services through the DRG system rather
than the actual hospital charges incurred. The increasing number
of morbidly obese patients and incremental resource use by these
patients will inevitably become a growing burden to hospital
ﬁnancial systems.
There are several limitations with this study. A study has
reported that the ratio of diagnosed to undiagnosed diabetes was
different depending on obesity levels in the United States [8].
That is, between National Health and Nutrition Examination
Survey (NHANES) II (1976–1980) and NHANES 1999–2000,
the proportion of total diabetes cases that was diagnosed
increased from 41% to 83% among individuals with BMI  35.
However, there was no increase in the percent of total diabetes
cases that were diagnosed among individuals with BMI < 35.
Therefore, the association between obesity and diabetes could be
potentially overestimated because of a higher awareness and
detection of diabetes among obese individuals. Each observation
in the NIS is a hospital discharge record rather than a patient.
The patient identiﬁer was not available in the NIS data and some
patients may have had more than one episode of hospitalization.
Multiple hospitalizations are common among patients with dia-
betes [28]. Because all hospital admissions are subject to resource
utilization, the inclusion of multiple hospitalizations is not a
limitation to our main objective of study. However, we could not
describe the characteristics of patients with diabetes who were
repeatedly admitted.
NIS is hospital administrative data which does not include the
body measurements of patients. If available, to reduce a potential
classiﬁcation bias, BMI would be ideal measurement in identify-
ing obesity. A study has reported an undercoding of obesity in
medical records [29]. If physicians failed to note the obesity or
morbid obesity of patients’ conditions, then the incremental hos-
pital charges of those patients compared with nonobese patients
could be even larger because higher hospital charges of obese
patients may be counted as nonobese patients. Therefore, the
study results we presented should be understood as a “minimum
difference” in hospital charges among different levels of obesity.
Conclusions
Obesity has a sizeable economic burden and it is a well estab-
lished risk factor for diabetes. In this study, obesity has been
shown to be a risk factor for both type 1 and type 2 diabetes
inpatients. Patients with diabetes were considerably more likely
to be obese or morbidly obese compared with those inpatients
without diabetes. Additionally, this study found that obesity and
morbid obesity is a risk factor for increased hospital resource
consumption regardless of their types or presence of diabetes and
other characteristics such as sex, age, race, hospital admission
type, or length of hospital stay. Particularly, the hospital charges
among morbidly obese inpatients were considerably higher
728 Kim and Boye
compared with their counterparts. Because of high levels of hos-
pital resource consumption, the rapidly increasing prevalence of
morbid obesity among inpatients is likely to be a burden to
hospital ﬁnance systems.
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